387 related articles for article (PubMed ID: 19153143)
1. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
Blank N; Max R; Schiller M; Briem S; Lorenz HM
Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
[No Abstract] [Full Text] [Related]
2. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
3. Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?
Yazici Y; Erkan D
Ann Rheum Dis; 2004 May; 63(5):607-8; author reply 608. PubMed ID: 15082503
[No Abstract] [Full Text] [Related]
4. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
Malesci D; La Montagna G
Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
[No Abstract] [Full Text] [Related]
5. Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?
O'Dell JR
N Engl J Med; 1999 Jan; 340(4):310-2. PubMed ID: 9920958
[No Abstract] [Full Text] [Related]
6. The role of tumor necrosis factor inhibitors in patients with RA.
Trethewey P
JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
[No Abstract] [Full Text] [Related]
7. [TNF antagonists in therapy of rheumatoid arthritis].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
[No Abstract] [Full Text] [Related]
8. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
Nagashima T; Okubo-Fornbacher H; Aoki Y; Kamata Y; Kimura H; Kamimura T; Nara H; Iwamoto M; Yoshio T; Okazaki H; Minota S
J Rheumatol; 2008 May; 35(5):936-8. PubMed ID: 18464318
[No Abstract] [Full Text] [Related]
9. Biologic therapy for rheumatoid arthritis.
Klippel JH
N Engl J Med; 2000 Nov; 343(22):1640-1. PubMed ID: 11096174
[No Abstract] [Full Text] [Related]
10. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
Kaplan MJ
Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
[No Abstract] [Full Text] [Related]
11. Etanercept in rheumatoid arthritis.
Ferraccioli GF; Di Poi E
N Engl J Med; 1999 Jun; 340(25):2000-1. PubMed ID: 10383275
[No Abstract] [Full Text] [Related]
12. Anti-tumour necrosis factor therapy in the West Midlands.
Bartram D; Sheeran T; Price T; Mulherin D
Rheumatology (Oxford); 2004 Mar; 43(3):400; author reply 400-1. PubMed ID: 14963219
[No Abstract] [Full Text] [Related]
13. Etanercept or infliximab: the patient's considerations.
Sherrick RC
Arch Intern Med; 2006 Jul; 166(13):1418; author reply 1418. PubMed ID: 16832010
[No Abstract] [Full Text] [Related]
14. Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database.
Ostergaard M; Unkerskov J; Linde L; Krogh NS; Ravn T; Ringsdal VS; Petri A; Andersen LS; Tarp U; Hansen A; Hjardem E; Hetland ML
Scand J Rheumatol; 2007; 36(2):151-4. PubMed ID: 17476624
[No Abstract] [Full Text] [Related]
15. Etanercept in rheumatoid arthritis.
Cook DA; Dimick JB; Gallagher DC
N Engl J Med; 1999 Jun; 340(25):2000; author reply 2001. PubMed ID: 10383273
[No Abstract] [Full Text] [Related]
16. Rheumatoid arthritis.
Emery P; Suarez-Almazor M
Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
[No Abstract] [Full Text] [Related]
17. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
[TBL] [Abstract][Full Text] [Related]
18. Septic arthritis caused by Rothia dentocariosa in a patient with rheumatoid arthritis receiving etanercept therapy.
Favero M; Raffeiner B; Cecchin D; Schiavon F
J Rheumatol; 2009 Dec; 36(12):2846-7. PubMed ID: 19966198
[No Abstract] [Full Text] [Related]
19. Treatment of rheumatoid arthritis with etanercept.
Genovese MC; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
[TBL] [Abstract][Full Text] [Related]
20. Psoriatic arthritis patients doing better on infliximab than etanercept.
Smith N; Gadsby K; Deighton C
Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
[No Abstract] [Full Text] [Related]
[Next] [New Search]
